Over nearly 2.5 years, most lives saved by COVID-19 vaccination were in older adults by first booster dose and during the Omicron period, reinforcing the importance of up-to-date vaccination among the most at-risk individuals.

With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.

As bird flu is confirmed in 33 cattle herds across eight US states, science editor of the Guardian Ian Sample talks to virologist Dr Ed Hutchinson of Glasgow University and ESWI Board member about why this development has taken scientists by surprise

Hosted by UKHSA and initially chaired by Dame Jenny Harries, the new Network will strengthen disease surveillance and outbreak response across the European Region

In this episode, ECDC expert on respiratory viruses, Nick Bundle, gives the lowdown on the European Respiratory Virus Surveillance Summary (ERVISS), a new surveillance tool which presents weekly data on influenza, SARS-CoV-2 and RSV.

Previous comparative analyses of people admitted to hospital for COVID-19 versus influenza evaluated the risk of death, hospital readmission, and a narrow set of health outcomes up to 6 months following infection.

The Global Preparedness Monitoring Board (GPMB) 2023 Report points out that global preparedness for pandemics and other disease outbreaks remains inadequate, making four key recommendations to urgently strengthen global preparedness.

This interactive dashboard provides a weekly integrated epidemiological summary for influenza, RSV and severe acute respiratory syndrome coronavirus 2 for the EU/EEA and the WHO European Region

ESWI 2023: 10 key take home messages

The Vaccine Monitoring Platform (VMP) is a collaboration between EMA and ECDC for the timely generation of independent real-world evidence (RWE) on the safety and effectiveness of vaccines in use in EU/EEA immunisation programs.

National Influenza Centers have played a crucial role in the surveillance of SARS-CoV-2. The FluCov project, covering 22 countries, was initiated to monitor the impact of the SARS-CoV-2 pandemic on influenza activity.